Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH SURI STUDY
jRCTs031220080Completed
- Sponsor
- FUJI YAKUHIN CO., LTD
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dotinurad in hyperuricemia, sponsored by FUJI YAKUHIN CO., LTD. Primary endpoint: Proportion achieving target serum uric acid at week 24. Started May 2022; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on jRCTs031220080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220080.